The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation

201831 citationsJournal Article

Authors

Good health and well-being

Published in: Surgical Oncology

Volume 27, Issue 4, pp. 702-708

Field-Weighted Citation Impact: 1.30